Cargando…

Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease

The heterogeneity of biological processes driving the severity of nonalcoholic fatty liver disease (NAFLD) as reflected in the transcriptome and the relationship between the pathways involved are not well established. Well-defined associations between gene expression profiles and disease progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoang, Stephen A., Oseini, Abdul, Feaver, Ryan E., Cole, Banumathi K., Asgharpour, Amon, Vincent, Robert, Siddiqui, Mohammad, Lawson, Mark J., Day, Nathan C., Taylor, Justin M., Wamhoff, Brian R., Mirshahi, Faridoddin, Contos, Melissa J., Idowu, Michael, Sanyal, Arun J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715650/ https://www.ncbi.nlm.nih.gov/pubmed/31467298 http://dx.doi.org/10.1038/s41598-019-48746-5

Ejemplares similares

An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis
por: Luo, Yi, et al.
Publicado: (2018)

Second-Harmonic Generated Quantifiable Fibrosis Parameters Provide Signatures for Disease Progression and Regression in Nonalcoholic Fatty Liver Disease
por: Ng, Nicole, et al.
Publicado: (2023)

The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
por: Cazanave, Sophie, et al.
Publicado: (2017)

Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease
por: Pacana, Tommy, et al.
Publicado: (2015)

Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
por: Cazanave, Sophie, et al.
Publicado: (2020)

The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma
por: Koelsch, Nicholas, et al.
Publicado: (2023)

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)

Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk
por: Feaver, Ryan E., et al.
Publicado: (2023)

Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
por: Mirshahi, Faridoddin, et al.
Publicado: (2022)

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
por: Asgharpour, Amon, et al.
Publicado: (2016)

Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development
por: Kriss, Michael, et al.
Publicado: (2020)

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Restoration of CD4(+) T Cells during NAFLD without Modulation of the Hepatic Immunological Pattern Is Not Sufficient to Prevent HCC
por: Isbell, Madison, et al.
Publicado: (2022)

Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids
por: Muthiah, Mark D., et al.
Publicado: (2022)

Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD
por: Smirnova, Ekaterina, et al.
Publicado: (2022)

Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
por: Shepherd, Emma L., et al.
Publicado: (2020)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
por: Noureddin, Mazen, et al.
Publicado: (2019)

Exposure of Induced Pluripotent Stem Cell‐Derived Vascular Endothelial and Smooth Muscle Cells in Coculture to Hemodynamics Induces Primary Vascular Cell‐Like Phenotypes
por: Collado, Maria S., et al.
Publicado: (2017)

The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance
por: Gill, Ryan M., et al.
Publicado: (2023)

The transcontinental variability of nonalcoholic fatty liver disease
por: Oliveira, Claudia P., et al.
Publicado: (2020)

Adalimumab treatment in Crohn’s disease: an overview of long-term efficacy and safety in light of the EXTEND trial
por: Asgharpour, Amon, et al.
Publicado: (2013)

Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
por: Cariou, Bertrand, et al.
Publicado: (2021)

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
por: Estes, Chris, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease is specifically related to the risk of hepatocellular cancer but not extrahepatic malignancies
por: Albhaisi, Somaya, et al.
Publicado: (2022)

Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells
por: Yu, Shan, et al.
Publicado: (2022)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
por: Bahrami, Hossein, et al.
Publicado: (2003)

SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
por: Luo, Yi, et al.
Publicado: (2021)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Withaferin A Acts as a Novel Regulator of Liver X Receptor-α in HCC
por: Shiragannavar, Varsha D., et al.
Publicado: (2021)

Enemy at the water cooler: real-life stories of insider threats and Enterprise Security Management countermeasures
por: Contos, Brian T
Publicado: (2006)

Physical and logical security convergence: powered by enterprise security management
por: Contos, Brian T
Publicado: (2007)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

Multi-SNP Analysis of GWAS Data Identifies Pathways Associated with Nonalcoholic Fatty Liver Disease
por: Chen, Qing-Rong, et al.
Publicado: (2013)

NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis
por: Harrison, Stephen A., et al.
Publicado: (2019)

Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction
por: Raghav, K., et al.
Publicado: (2016)

Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemic
por: Filozof, Claudia, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation
por: Brunt, Elizabeth M.
Publicado: (2016)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vl0jj0di3l1hna3if553sa74mj